PTK2 and ischemia: In another study, a transgenic mouse expressing a super-activatable FAK mutant (K578E/K581E, termed SuperFAK) with increased FAK catalytic activity had a decreased infarct area following ischemia/reperfusion [83], suggesting that FAK activity within CMs is critical for protection against ischemia/reperfusion injury.